Avrobio Inc (AVRO) has released an update to notify the public and investors about a regulation fd disclosure.
AVROBIO, Inc. and Tectonic Therapeutic, Inc. conducted a live webcast on January 30, 2024, to discuss their merger agreement, where Tectonic will become a wholly owned subsidiary of AVRO after merging with Alpine Merger Subsidiary, Inc. The webcast, along with the investor presentation slides, is accessible on AVRO’s website and will be archived for 30 days. The presentation materials are included as part of the official record but are not considered legally “filed” under the Securities Exchange Act of 1934.
For further insights into AVRO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
